Skip to main content
Have a personal or library account? Click to login
Fluorodeoxyglucose Applications in Cardiac PET: Viability, Inflammation, Infection, and Beyond Cover

Fluorodeoxyglucose Applications in Cardiac PET: Viability, Inflammation, Infection, and Beyond

Open Access
|Apr 2020

References

  1. Al-Mallah MH Sitek A Moore SC Di Carli M Dorbala S Assessment of myocardial perfusion and function with PET and PET/CT J Nucl Cardiol 2010 Jun 17 3 498 513
  2. Khalaf S Chamsi-Pasha M Al-Mallah MH Assessment of myocardial viability by PET Curr Opin Cardiol 2019 Sep 34 5 466 72
  3. Jamiel A Ebid M Ahmed AM Ahmed D Al-Mallah MH The role of myocardial viability in contemporary cardiac practice Heart Fail Rev 2017 Jul 22 4 401 13
  4. Allman KC Shaw LJ Hachamovitch R Udelson JE Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 2002 Apr 3 39 7 1151 8
  5. Ghosh N Rimoldi OE Beanlands RS Camici PG Assessment of myocardial ischaemia and viability: role of positron emission tomography Eur Heart J 2010 Dec 31 24 2984 95
  6. Dilsizian V Bacharach SL Beanlands RS ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures J Nucl Cardiol 2016 Oct 23 5 1187 226
  7. Di Carli MF Asgarzadie F Schelbert HR Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy Circulation 1995 Dec 15 92 12 3436 44
  8. Beanlands RS Nichol G Huszti E F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2) J Am Coll Cardiol 2007 Nov 13 50 20 2002 12
  9. Yancy CW Jessup M Bozkurt B 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 2013 Oct 15 128 16 1810 52
  10. Yancy CW Jessup M Bozkurt B 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America J Am Coll Cardiol 2017 Aug 8 70 6 776 803
  11. Rischpler C Langwieser N Souvatzoglou M PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake Eur Heart J Cardiovasc Imaging 2015 Jun 16 6 661 9
  12. Nensa F Beiderwellen K Heusch P Wetter A Clinical applications of PET/MRI: current status and future perspectives Diagn Interv Radiol 2014 Sep–Oct 20 5 438 47
  13. Birnie DH Sauer WH Bogun F HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis Heart Rhythm 2014 Jul 11 7 1305 23
  14. Chareonthaitawee P Beanlands RS Chen W Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring J Nucl Cardiol 2017 Oct 24 5 1741 58
  15. Schatka I Bengel FM Advanced imaging of cardiac sarcoidosis J Nucl Med 2014 Jan 55 1 99 106
  16. Chang TI Chi NH Chou NK Isolated cardiac sarcoidosis in heart transplantation Transplant Proc 2012 May 44 4 903 6
  17. Greulich S Deluigi CC Gloekler S CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis JACC Cardiovasc Imaging 2013 Apr 6 4 501 11
  18. Patel MR Cawley PJ Heitner JF Detection of myocardial damage in patients with sarcoidosis Circulation 2009 Nov 17 120 20 1969 77
  19. Blankstein R Osborne M Naya M Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis J Am Coll Cardiol 2014 Feb 4 63 4 329 36
  20. Blankstein R Waller AH Evaluation of Known or Suspected Cardiac Sarcoidosis Circ Cardiovasc Imaging 2016 Mar 9 3 e000867
  21. Vita T Okada DR Veillet-Chowdhury M Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis Circ Cardiovasc Imaging 2018 Jan 11 1 e007030
  22. White JA Rajchl M Butler J Thompson RT Prato FS Wisenberg G Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography–magnetic resonance imaging for the diagnosis of cardiac disease Circulation 2013 Jun 4 127 22 e639 41
  23. Al-Mallah MH Aljizeeri A Villines TC Srichai MB Alsaileek A Cardiac computed tomography in current cardiology guidelines J Cardiovasc Comput Tomogr 2015 Nov–Dec 9 6 514 23
  24. Murdoch DR Corey GR Hoen B International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study Arch Intern Med 2009 Mar 9 169 5 463 73
  25. Habib G Erba PA Iung B Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study Eur Heart J 2019 Oct 14 40 39 3222 32
  26. Saby L Laas O Habib G Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion J Am Coll Cardiol 2013 Jun 11 61 23 2374 82
  27. Juneau D Golfam M Hazra S Molecular Imaging for the diagnosis of infective endocarditis: A systematic literature review and meta-analysis Int J Cardiol 2018 Feb 15 253 183 8
  28. Kim J Feller ED Chen W Liang Y Dilsizian V FDG PET/CT for Early Detection and Localization of Left Ventricular Assist Device Infection: Impact on Patient Management and Outcome JACC Cardiovasc Imaging 2019 Apr 12 4 722 9
  29. Scholtens AM Swart LE Verberne HJ Tanis W Lam MG Budde RP Confounders in FDG-PET/CT Imaging of Suspected Prosthetic Valve Endocarditis JACC Cardiovasc Imaging 2016 Dec 9 12 1462 5
  30. Calais J Touati A Grall N Diagnostic Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and White Blood Cell SPECT/Computed Tomography in Patients With Suspected Cardiac Implantable Electronic Device Chronic Infection Circ Cardiovasc Imaging 2019 Jul 12 7 e007188
  31. Tanis W Habets J van den Brink RB Symersky P Budde RP Chamuleau SA Differentiation of thrombus from pannus as the cause of acquired mechanical prosthetic heart valve obstruction by non-invasive imaging: a review of the literature Eur Heart J Cardiovasc Imaging 2014 Feb 15 2 119 29
  32. Scholtens AM Swart LE Kolste HJT Budde RP Lam MG Verberne HJ Standardized uptake values in FDG PET/CT for prosthetic heart valve endocarditis: a call for standardization J Nucl Cardiol 2018 Dec 25 6 2084 91
Language: English
Page range: 122 - 129
Published on: Apr 1, 2020
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2020 Shaden Khalaf, Mouaz H. Al-Mallah, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.